The store will not work correctly when cookies are disabled.
3,3'-(5-(4-bromophenyl)-1H-pyrrole-1,2-diyl)dipropanoic acid
ID: ALA4540854
PubChem CID: 1312632
Max Phase: Preclinical
Molecular Formula: C16H16BrNO4
Molecular Weight: 366.21
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)CCc1ccc(-c2ccc(Br)cc2)n1CCC(=O)O
Standard InChI: InChI=1S/C16H16BrNO4/c17-12-3-1-11(2-4-12)14-7-5-13(6-8-15(19)20)18(14)10-9-16(21)22/h1-5,7H,6,8-10H2,(H,19,20)(H,21,22)
Standard InChI Key: MCFIWWZBEUXLJM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
15.0355 -15.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8527 -15.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1070 -14.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4441 -14.3421 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7853 -14.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8846 -14.5728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4911 -15.1204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2686 -14.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8752 -15.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4397 -14.0699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4428 -13.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7345 -13.1174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7332 -12.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0249 -11.8927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4403 -11.8905 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0080 -14.5721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8410 -13.7740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0645 -13.5218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4566 -14.0691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6303 -14.8719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4065 -15.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6789 -13.8180 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
13 15 1 0
5 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.21 | Molecular Weight (Monoisotopic): 365.0263 | AlogP: 3.41 | #Rotatable Bonds: 7 |
Polar Surface Area: 79.53 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.69 | CX Basic pKa: ┄ | CX LogP: 3.17 | CX LogD: -2.92 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: -0.59 |
References
1. (2018) Methods and compositions for inhibiting cnksr1, |